Home - Clinical Trials Arena
Migraine in Major Markets, Disease Management, Epidemiology, Pipeline Asses... $10995. M&A in the Contract Manufacturing Industry: Implications and Outlook - ... $4995. Cell & gene therapy in pharma: CAR-T cell based therapies... $250. 1 of 2.
Positive topline data from Phase II trial of Vaxart’s norovirus …
Jul 7, 2023 · US-based Vaxart has announced positive topline data in a Phase II trial of its norovirus vaccine candidate. Preliminary results of the Phase II trial (NCT05626803) of the oral pill bivalent showed robust immune responses across all doses at day 29. Both doses showed a similar increase in antibody responses with no statistical difference between ...
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
Feb 2, 2023 · Pfizer and Moderna eye seasonal influenza. The two largest mRNA vaccine trials with readouts in 2023 are for seasonal influenza. First up, Moderna’s 6,102-patient, Phase III trial of mRNA-1010 (NCT05415462) has immunogenicity data expected in Q1 2023. The trial is testing mRNA-1010 against an active comparator vaccine, with primary endpoints ...
Longboard begins Phase III Dravet syndrome treatment trial
Sep 27, 2024 · Longboard Pharmaceuticals has commenced the international Phase III DEEp SEA Study of its investigational asset bexicaserin (LP352) for treating seizures in Dravet syndrome patients. The placebo-controlled, double-blind trial will enrol approximately 160 subjects between the ages of two and 65 years. LOA and PTSR Model - BMB-101 in Dravet ...
Novo Nordisk launches trial of pipeline drug CagriSema versus …
Nov 17, 2023 · Novo Nordisk launches trial of pipeline drug CagriSema versus newly approved Zepbound. The launch of this Phase III comparative trial by Novo Nordisk might imply that CagriSema and Zepbound are expected to become direct competitors once Novo Nordisk’s candidate reaches the market.
Alzheimer's trials: How does donanemab compare to lecanemab?
Jan 13, 2023 · Already, 2023 is shaping up to be an eventful year in Alzheimer’s disease (AD) drug development. After the FDA’s approval of Eisai/Biogen’s Leqembi (lecanemab) on January 6, the AD field is now looking toward the upcoming approval decision for Lilly’s donanemab expected in May. Although both donanemab and lecanemab have similar therapeutic targets, the two …
Obesity: Six trials to watch over the next 12 months
Jun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
HIV: Three trials to watch in 2024 - Clinical Trials Arena
Dec 18, 2023 · The Phase IIa trial (NCT05947890) is investigating the safety and immunogenicity of the vaccine candidate and primary completion is scheduled for November 2024. The study plans to enrol 276 patients and it will be conducted in two parts, A and B. Part A will include two cohorts; each cohort will have four groups.
MedinCell reports positive data from Covid-19 prevention trial
Jan 6, 2023 · MedinCell has reported positive data from the Phase II SAIVE clinical study of ivermectin in preventing Covid-19 infection in a contact-based population. The double-blind, parallel-group, randomised, placebo-controlled, multicentre trial was designed for assessing the efficacy and safety of ivermectin tablets, which are taken orally for 28 days.
Oxford University adds ivermectin to PRINCIPLE trial for Covid-19
Jun 23, 2021 · The University of Oxford in the UK has added ivermectin to the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) study for the treatment of Covid-19. PRINCIPLE is a large clinical trial designed to assess potential Covid-19 therapies for non-hospitalised patients, including at-home recovery ...